These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 26270237)
21. Quinoxaline derivatives as potential antitrypanosomal and antileishmanial agents. Cogo J; Cantizani J; Cotillo I; Sangi DP; Corrêa AG; Ueda-Nakamura T; Filho BPD; Martín JJ; Nakamura CV Bioorg Med Chem; 2018 Aug; 26(14):4065-4072. PubMed ID: 30100019 [TBL] [Abstract][Full Text] [Related]
22. Genomic and Spectroscopic Signature-Based Discovery of Natural Macrolactams. Shin YH; Im JH; Kang I; Kim E; Jang SC; Cho E; Shin D; Hwang S; Du YE; Huynh TH; Ko K; Ko YJ; Nam SJ; Awakawa T; Lee J; Hong S; Abe I; Moore BS; Fenical W; Yoon YJ; Cho JC; Lee SK; Oh KB; Oh DC J Am Chem Soc; 2023 Jan; 145(3):1886-1896. PubMed ID: 36634356 [TBL] [Abstract][Full Text] [Related]
23. In vitro activity of Triclisia patens and some bisbenzylisoquinoline alkaloids against Leishmania donovani and Trypanosoma brucei brucei. del Rayo Camacho M; Phillipson JD; Croft SL; Rock P; Marshall SJ; Schiff PL Phytother Res; 2002 Aug; 16(5):432-6. PubMed ID: 12203262 [TBL] [Abstract][Full Text] [Related]
24. Motobamide, an Antitrypanosomal Cyclic Peptide from a Takahashi H; Iwasaki A; Kurisawa N; Suzuki R; Jeelani G; Matsubara T; Sato T; Nozaki T; Suenaga K J Nat Prod; 2021 May; 84(5):1649-1655. PubMed ID: 33983736 [TBL] [Abstract][Full Text] [Related]
25. The Discovery of Weddellamycin, a Tricyclic Polyene Macrolactam Antibiotic from an Antarctic Deep-Sea-Derived Chen L; Liu K; Hong J; Cui Z; He W; Wang Y; Deng Z; Tao M Mar Drugs; 2024 Apr; 22(4):. PubMed ID: 38667806 [TBL] [Abstract][Full Text] [Related]
28. Antileishmanial and antitrypanosomal activity of symmetrical dibenzyl-substituted α,β-unsaturated carbonyl-based compounds. Alkhaldi AA; de Koning HP; Bukhari SNA Drug Des Devel Ther; 2019; 13():1179-1185. PubMed ID: 31118564 [No Abstract] [Full Text] [Related]
29. Structure-Based Virtual Screening and Biochemical Evaluation for the Identification of Novel Trypanosoma brucei Aldolase Inhibitors. Ferreira LLG; Ferreira RS; Palomino DL; Andricopulo AD Curr Top Med Chem; 2018; 18(5):397-405. PubMed ID: 29701141 [TBL] [Abstract][Full Text] [Related]
30. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei. Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349 [TBL] [Abstract][Full Text] [Related]
31. Sleeping sickness pathogen (Trypanosoma brucei) and natural products: therapeutic targets and screening systems. Hannaert V Planta Med; 2011 Apr; 77(6):586-97. PubMed ID: 20945274 [TBL] [Abstract][Full Text] [Related]
32. Mallotojaponins B and C: Total Synthesis, Antiparasitic Evaluation, and Preliminary SAR Studies. Grayfer TD; Grellier P; Mouray E; Dodd RH; Dubois J; Cariou K Org Lett; 2016 Feb; 18(4):708-11. PubMed ID: 26828239 [TBL] [Abstract][Full Text] [Related]
33. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis. Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695 [TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and antitrypanosomal activities of 2,6-disubstituted-4,5,7-trifluorobenzothiophenes. Bhambra AS; Edgar M; Elsegood MRJ; Li Y; Weaver GW; Arroo RRJ; Yardley V; Burrell-Saward H; Krystof V Eur J Med Chem; 2016 Jan; 108():347-353. PubMed ID: 26698538 [TBL] [Abstract][Full Text] [Related]
35. Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma brucei. Cleghorn LA; Albrecht S; Stojanovski L; Simeons FR; Norval S; Kime R; Collie IT; De Rycker M; Campbell L; Hallyburton I; Frearson JA; Wyatt PG; Read KD; Gilbert IH J Med Chem; 2015 Oct; 58(19):7695-706. PubMed ID: 26418485 [TBL] [Abstract][Full Text] [Related]
36. Folates in Trypanosoma brucei: Achievements and Opportunities. Cullia G; Tamborini L; Conti P; De Micheli C; Pinto A ChemMedChem; 2018 Oct; 13(20):2150-2158. PubMed ID: 30152195 [TBL] [Abstract][Full Text] [Related]
37. Synthesis of novel guttiferone A derivatives: in-vitro evaluation toward Plasmodium falciparum, Trypanosoma brucei and Leishmania donovani. Fromentin Y; Gaboriaud-Kolar N; Lenta BN; Wansi JD; Buisson D; Mouray E; Grellier P; Loiseau PM; Lallemand MC; Michel S Eur J Med Chem; 2013 Jul; 65():284-94. PubMed ID: 23727538 [TBL] [Abstract][Full Text] [Related]
38. Chemical constituents from Waltheria indica exert in vitro activity against Trypanosoma brucei and T. cruzi. Cretton S; Bréant L; Pourrez L; Ambuehl C; Perozzo R; Marcourt L; Kaiser M; Cuendet M; Christen P Fitoterapia; 2015 Sep; 105():55-60. PubMed ID: 26072041 [TBL] [Abstract][Full Text] [Related]
39. Development of novel drugs for human African trypanosomiasis. Brun R; Don R; Jacobs RT; Wang MZ; Barrett MP Future Microbiol; 2011 Jun; 6(6):677-91. PubMed ID: 21707314 [TBL] [Abstract][Full Text] [Related]